secwatch.observer — SEC 8-K summary
======================================

Issuer:     Twist Bioscience Corp (TWST)
CIK:        0001581280
Form:       8-K/A
Filed at:   2023-08-04T23:59:59+00:00
Accession:  0001104659-23-087548
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Twist Bioscience reports $12.7M restructuring costs, exceeding prior $9-11M estimate
--------------------------------------------------------------------------------

- Cumulative pre-tax restructuring costs of $12.7M recognized through June 30, 2023.
- Broke down as $8.6M severance, $3.6M asset impairments, and $0.4M other costs.
- Expects additional severance up to $0.4M and other costs up to $0.6M.
- Restructuring includes ~270 employee reduction (25% of workforce) and facility consolidation.
- Previous estimate of $9-11M was based on initial plan approved May 3, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1581280/000110465923087548/0001104659-23-087548-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1581280/000110465923087548/tm2322811d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-087548

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer